Last reviewed · How we verify
A Safety，Tolerability and Pharmacokinetics Clinical Trial of JX11502MA Capsule
The purpose of this study is to investigate the safety, tolerability and pharmacokinetic characteristics of JX11502MA capsule on healthy human, and to explore the relationship between the dose, pharmacokinetic parameters and safety of JX11502MA capsule，so as to provide basis for the follow-up clinical trials (multi-dose tolerability, pharmacokinetics and phase II trial, etc.).
Details
| Lead sponsor | Zhejiang Jingxin Pharmaceutical Co., Ltd. |
|---|---|
| Phase | PHASE1 |
| Status | UNKNOWN |
| Enrolment | 58 |
| Start date | Sat Jan 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Feb 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Schizophrenia
Interventions
- JX11502MA
- Placebo
Countries
China